Erlotinib 10-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Page(s): 508

Erlotinib 10-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Erlotinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, erlotinib, hazardous medication, cancer, antineoplastic agent, EGFR inhibitor

Related Categories: CANCER AND AIDS, FORMULATIONS, HAZARDOUS DRUGS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 508
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 511
Compounding for Cancer in Companion Animals Mixon William, Northrup Nicole, Vail Jane	Jan/Feb 2009 Pg. 42-49
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A	Jan/Feb 2003 Pg. 10-15 View Sample